(Q41151519)

27 September 2017

title

Psychotropic effects of ritanserin, a selective S2 antagonist: an open study (English)

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

2 December 2022

author name string

W. H. Strauss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1821698

2 December 2022

E. Klieser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1821698

2 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:0924977X9190710C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

https://api.elsevier.com/content/article/PII:0924977X9190710C?httpAccept=text/plain

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

European Neuropsychopharmacology

2 December 2022

published in

1 reference

27 September 2017

volume

1

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

101-105

1 reference

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

27 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

Increased whole blood serotonin concentrations in chronic schizophrenic patients

2 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0924-977X(91)90710-C

2 December 2022

Identifiers

1 reference

27 September 2017

1 reference